Fistula Global Clinical Trials Review, H2, 2015
Summary
GlobalDatas clinical trial report, “Fistula Global Clinical Trials Review, H2, 2015 provides an overview of Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Fistula to Other Diseases Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Fistula to Other Diseases Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Fistula Therapeutics Clinical Trials 26
Prominent Drugs 28
Latest Clinical Trials News on Fistula 29
Oct 22, 2015: Phase I Trial of Cytori Cell Therapy for Inflammatory Bowel Disease Published 29
Clinical Trial Profile Snapshots 30
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 52
Contact Us 52
Disclaimer 52
Source 53
List Of Tables
Fistula Therapeutics, Global, Clinical Trials by Region, 2015* 6
Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Fistula Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Fistula Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Fistula to Other Diseases Clinical Trials, G7 Countries (%), 2015* 13
Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Fistula to Other Diseases Clinical Trials, E7 Countries (%), 2015* 16
Fistula Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Fistula Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Fistula Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
List Of Figures
Fistula Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Fistula Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Fistula Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Proportion of Fistula to Other Diseases Clinical Trials, G7 Countries (%), 2015* 13
Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Fistula to Other Diseases Clinical Trials, E7 Countries (%), 2015* 16
Fistula Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Fistula Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Fistula Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Fistula Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 51
